ROPIX

Description

Composition: Ropinirole Hydrochloride

Product Type: Tablet

Quantity: 21 tablets

Strength/Dosage: 0.25 mg, 1 mg, or 2 mg per tablet

Indications:

Management of Parkinson’s disease, either as monotherapy or in combination with levodopa.
Treatment of moderate to severe primary Restless Legs Syndrome (RLS).
Improvement of motor symptoms in early and advanced stages of Parkinson’s disease.
Reduction of “off” episodes in Parkinson’s disease when used with levodopa.
Management of dopamine-related movement disorders (off-label in certain cases).